TELIX PHARMACEUTICALS

Serial Number 79257540
Registration 6908866
700

Registration Progress

Application Filed
Mar 14, 2019
Under Examination
Approved for Publication
Sep 13, 2022
Published for Opposition
Sep 13, 2022
Registered
Nov 29, 2022

Trademark Image

TELIX PHARMACEUTICALS

Basic Information

Serial Number
79257540
Registration Number
6908866
Filing Date
March 14, 2019
Registration Date
November 29, 2022
Published for Opposition
September 13, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 29, 2022
Registration
Registered
Classes
005 010

Rights Holder

Telix Pharmaceuticals Limited

99
Address
Suite 401, 55 Flemington Road
North Melbourne VIC 3051
AU

Ownership History

Telix Pharmaceuticals Limited

Original Applicant
99
AU

Telix Pharmaceuticals Limited

Owner at Publication
99
AU

Telix Pharmaceuticals Limited

Original Registrant
99
AU

Legal Representation

Attorney
Andrew S. Ehard

USPTO Deadlines

Next Deadline
1074 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20221129)
Due Date
November 29, 2028
Grace Period Ends
May 29, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Apr 19, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Mar 16, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 16, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 28, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 29, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 29, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 13, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 13, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 11, 2022 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Aug 24, 2022 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 24, 2022 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Aug 24, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 15, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 10, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 10, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 10, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 10, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 10, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 9, 2022 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW Loading...
Aug 9, 2022 LIMS I LIMITATION OF GOODS/SERVICES FROM IB ENTERED Loading...
Oct 3, 2021 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Aug 24, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 23, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 23, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 15, 2021 LIMS I LIMITATION OF GOODS/SERVICES FROM IB ENTERED Loading...
Jul 31, 2021 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Mar 12, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 12, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 12, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 18, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 17, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 17, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 17, 2020 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Sep 30, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Sep 30, 2020 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Aug 17, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 17, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 17, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 13, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 13, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 13, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 12, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 10, 2020 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 13, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 13, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 12, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 14, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...

Detailed Classifications

Class 005
Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products for use in the treatment, prevention, or diagnosis of cancer
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing cancer; drug delivery systems for the treatment, prevention, or diagnosis of cancer, namely, applicators for pharmaceutical preparations sold without medication for use in the treatment, prevention, or diagnosis of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"